Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Soverini

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Blood|September 20, 2011
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemiasFranck Emmanuel Nicolini, Grzegorz W Basak, Simona Soverini, et al.
Hematological Oncology|April 29, 2024
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysisMariarita Sciumè, Fabio Serpenti, Roberta Zanotti, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
Journal of Oncology|December 13, 2019
Identification of Two <i>DNMT3A</i> Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid LeukemiaSamantha Bruno, Maria Teresa Bochicchio, Eugenia Franchini, et al.
Leukemia|December 2, 2020
BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGSSimona Soverini, Margherita Martelli, Luana Bavaro, et al.
Blood|September 21, 2011
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti, et al.
Blood|July 11, 2009
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)Ilaria Iacobucci, Clelia Tiziana Storlazzi, Daniela Cilloni, et al.
Haematologica|July 30, 2016
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patientsFausto Castagnetti, Massimo Breccia, Gabriele Gugliotta, et al.
Haematologica|June 27, 2015
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemiaGabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et al.
Blood|May 17, 2013
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemiaDomenico Russo, Giovanni Martinelli, Michele Malagola, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Blood|September 20, 2011
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemiasFranck Emmanuel Nicolini, Grzegorz W Basak, Simona Soverini, et al.
Hematological Oncology|April 29, 2024
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysisMariarita Sciumè, Fabio Serpenti, Roberta Zanotti, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
Journal of Oncology|December 13, 2019
Identification of Two <i>DNMT3A</i> Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid LeukemiaSamantha Bruno, Maria Teresa Bochicchio, Eugenia Franchini, et al.
Leukemia|December 2, 2020
BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGSSimona Soverini, Margherita Martelli, Luana Bavaro, et al.
Blood|September 21, 2011
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti, et al.
Blood|July 11, 2009
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)Ilaria Iacobucci, Clelia Tiziana Storlazzi, Daniela Cilloni, et al.
Haematologica|July 30, 2016
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patientsFausto Castagnetti, Massimo Breccia, Gabriele Gugliotta, et al.
Haematologica|June 27, 2015
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemiaGabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et al.
Blood|May 17, 2013
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemiaDomenico Russo, Giovanni Martinelli, Michele Malagola, et al.
Pageof 17